(a) No pharmacist or pharmacy shall reveal any records or information concerning the nature of pharmaceutical services rendered to a patient without the oral or written consent of the patient or the patient's agent. If a patient or a patient's agent gives oral consent to release records or information, the pharmacist shall promptly record, in writing or in electronic data base form, the oral consent by listing the patient's name, the name of the patient's agent, if applicable, the date and the nature of the records or information released.
(b) Notwithstanding subsection (a) of this section, a pharmacist or pharmacy may provide pharmacy records or information to the following: (1) The patient; (2) the prescribing practitioner or a pharmacist or another prescribing practitioner presently treating the patient when deemed medically appropriate; (3) a person registered or licensed pursuant to chapter 378 who is acting as an agent for a prescribing practitioner that is presently treating the patient or a person registered or licensed pursuant to chapter 378 providing care to the patient in a hospital; (4) third party payors who pay claims for pharmaceutical services rendered to a patient or who have a formal agreement or contract to audit any records or information in connection with such claims; (5) any governmental agency with statutory authority to review or obtain such information; (6) any individual, the state or federal government or any agency thereof or court pursuant to a subpoena; and (7) any individual, corporation, partnership or other legal entity which has a written agreement with a pharmacy to access the pharmacy's database provided the information accessed is limited to data which does not identify specific individuals.
(P.A. 95-85; P.A. 99-175, S. 44.)
History: P.A. 99-175 amended Subsec. (b) to make technical changes.
Subsec. (a):
Statute is intended to protect information concerning the nature of customer's treatment and not pharmacy's billing practices. 53 CA 129.
Subsec. (b):
Pharmacy required to comply with investigative demand of commissioner; civil investigative demand determined to be equivalent of subpoena. 53 CA 129.
Structure Connecticut General Statutes
Section 20-570. - Short title: Pharmacy Practice Act.
Section 20-571. (Formerly Sec. 20-184a). - Definitions.
Section 20-572. (Formerly Sec. 20-163). - Commission of Pharmacy. Appointment and term of members.
Section 20-573. (Formerly Sec. 20-165). - Meetings of commission. Records.
Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.
Section 20-575. - Powers and responsibilities.
Section 20-576. (Formerly Sec. 20-164). - Regulations.
Section 20-576a. - Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.
Section 20-578. (Formerly Sec. 21a-306). - Information not to be disclosed. Exception.
Section 20-580. (Formerly Sec. 20-167). - Revocation or suspension of nonlegend drug permit.
Section 20-581. (Formerly Sec. 20-185). - Penalty for violation of Pharmacy Practice Act. Exception.
Section 20-582. (Formerly Sec. 20-176). - Appeals of decisions of Commission of Pharmacy.
Section 20-583. - Where appeals returnable.
Section 20-591. - Graduates of foreign pharmacy schools. Regulations.
Section 20-596. (Formerly Sec. 20-168b). - Ownership of pharmacies by prescribing practitioners.
Section 20-598. (Formerly Sec. 20-177). - Registration of pharmacy interns.
Section 20-598a. - Registration and certification of pharmacy technicians.
Section 20-599. (Formerly Sec. 20-174a). - Continuing education: Definitions.
Section 20-605. - Practice of pharmacy without license or temporary permit prohibited.
Section 20-606. (Formerly Sec. 20-178). - Use of the title “pharmacist”.
Section 20-611. (Formerly Sec. 20-175b). - Advertising legend drug prices.
Section 20-612. - Only pharmacy may accept prescription for dispensing.
Section 20-617a. - Flavoring agent added to prescription product.
Section 20-618. (Formerly Sec. 21a-107). - Repackaged drugs not considered misbranded, when.
Section 20-623. - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.
Section 20-624. - Permit to sell nonlegend drugs.
Section 20-625. - Nonlegend veterinary drugs.
Section 20-626. - Confidentiality of pharmacy records.
Section 20-627. - Nonresident pharmacy. Definitions. Certificate of registration. Requirements.
Section 20-628. - Shipping, mailing or delivering legend devices or drugs.
Section 20-630. - Advertising.
Section 20-633. - Administration of vaccines by licensed pharmacists. Regulations.
Section 20-633a. - Pharmacy rewards program. Plain language summary. Violation.
Section 20-633b. - Sterile compounding pharmacies. Requirements. Regulations.
Section 20-633c. - Prescribing of opioid antagonists by licensed pharmacists. Regulations.
Section 20-633i. - Issuance of prescriptions for epinephrine auto injectors by pharmacists.
Section 20-636. - Sign re storage and disposal of prescription drugs.